Hemangioma medical therapy

Hemangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemangioma medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemangioma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemangioma medical therapy
CDC on Hemangioma medical therapy
Hemangioma medical therapy in the news
Blogs on Hemangioma medical therapy
Directions to Hospitals Treating Hemangioma
Risk calculators and risk factors for Hemangioma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Medical Therapy

• Medical and surgical options are available for the treatment of “problematic” hemangiomas.
• Medical management includes one or more systemic therapies.
• For massive and life-threatening disease:

• Corticosteroids
• Interferon
• Vincristine

• These agents have also been used for:

• Multifocal disease
• Visceral involvement
• Segmental distribution
• Airway obstruction
• Periorbital lesions